Next Article in Journal
Differential Development of Glucose Intolerance and Pancreatic Islet Adaptation in Multiple Diet Induced Obesity Models
Next Article in Special Issue
Risk of Parenteral Nutrition in Neonates—An Overview
Previous Article in Journal
Consequences of Essential Fatty Acids
Previous Article in Special Issue
Low Zinc Status and Absorption Exist in Infants with Jejunostomies or Ileostomies Which Persists after Intestinal Repair
Open AccessArticle

Preresection Obesity Increases the Risk of Hepatobiliary Complications in Short Bowel Syndrome

The University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE 68198, USA
University of the Witwatersrand, Johannesburg, 1 Jan Smuts Avenue, Braamfontein 2000, Johannesburg, South Africa
Author to whom correspondence should be addressed.
Nutrients 2012, 4(10), 1358-1366;
Received: 28 June 2012 / Revised: 11 September 2012 / Accepted: 18 September 2012 / Published: 26 September 2012
(This article belongs to the Special Issue Parenteral Nutrition)
PDF [363 KB, uploaded 26 September 2012]


Patients developing the short bowel syndrome (SBS) are at risk for hepatobiliary disease, as are morbidly obese individuals. We hypothesized that morbidly obese SBS individuals would be at increased risk for developing hepatobiliary complications. We reviewed 79 patients with SBS, 53 patients with initial body mass index (BMI) < 35 were controls. Twenty-six patients with initial BMI > 35 were the obese group. Obese patients were more likely to be weaned off parenteral nutrition (PN) (58% vs. 21%). Pre-resection BMI was significantly lower in controls (26 vs. 41). BMI at 1, 2, and 5 years was decreased in controls but persistently increased in obese patients. Obese patients were more likely to undergo cholecystectomy prior to SBS (42% vs. 32%) and after SBS (80% vs. 39%, p < 0.05). Fatty liver was more frequent in the obese group prior to SBS (23% vs. 0%, p < 0.05) but was similar to controls after SBS (23% vs. 15%). Fibrosis (8% vs. 13%) and cirrhosis/portal hypertension (19% vs. 21%) were similar in obese and control groups. Overall, end stage liver disease (ESLD) was similar in obese and control groups (19% vs. 11%) but was significantly higher in obese patients receiving PN (45% vs. 14%, p < 0.05). Obese patients developing SBS are at increased risk of developing hepatobiliary complications. ESLD was similar in the two groups overall but occurs more frequently in obese patients maintained on chronic PN. View Full-Text
Keywords: short bowel syndrome; obesity; hepatobiliary disease short bowel syndrome; obesity; hepatobiliary disease
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Thompson, J.S.; Weseman, R.A.; Rochling, F.A.; Grant, W.J.; Botha, J.F.; Langnas, A.N.; Mercer, D.F. Preresection Obesity Increases the Risk of Hepatobiliary Complications in Short Bowel Syndrome. Nutrients 2012, 4, 1358-1366.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top